Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126272031 | 12627203 | 1 | I | 20160728 | 20160805 | 20160805 | EXP | GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-49934BI | BOEHRINGER INGELHEIM | FLOYD C,ADEEL M,WOLFF C,JULU P,SHAH M,COLLIER D,ET AL. FIRST-IN-MAN TREATMENT OF SEVERE BLOOD PRESSURE VARIABILITY WITH BAROREFLEX ACTIVATION THERAPY. INTERNATIONAL JOURNAL OF CARDIOLOGY 2016;220:577-579. | 49.00 | YR | M | Y | 0.00000 | 20160805 | OT | COUNTRY NOT SPECIFIED | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126272031 | 12627203 | 1 | PS | CATAPRES | CLONIDINE HYDROCHLORIDE | 1 | Unknown | 1350 MG | N | 17407 | 450 | MG | TID | ||||||
| 126272031 | 12627203 | 2 | SS | CATAPRES | CLONIDINE HYDROCHLORIDE | 1 | Transdermal | 100 MCG | N | 17407 | 100 | UG | QD | ||||||
| 126272031 | 12627203 | 3 | C | PRAZOSIN | PRAZOSIN | 1 | Unknown | 18 MG | 0 | 9 | MG | BID | |||||||
| 126272031 | 12627203 | 4 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | 225 MG | 0 | 75 | MG | TID | |||||||
| 126272031 | 12627203 | 5 | C | METHYLDOPA. | METHYLDOPA | 1 | Unknown | 750 MG | 0 | 250 | MG | TID | |||||||
| 126272031 | 12627203 | 6 | C | DIAZEPAM. | DIAZEPAM | 1 | Unknown | 0 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126272031 | 12627203 | 1 | Blood pressure increased |
| 126272031 | 12627203 | 3 | Product used for unknown indication |
| 126272031 | 12627203 | 4 | Product used for unknown indication |
| 126272031 | 12627203 | 5 | Blood pressure increased |
| 126272031 | 12627203 | 6 | Blood pressure increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126272031 | 12627203 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126272031 | 12627203 | Autoimmune neuropathy | |
| 126272031 | 12627203 | Autonomic nervous system imbalance | |
| 126272031 | 12627203 | Drug ineffective | |
| 126272031 | 12627203 | Sjogren's syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |